P. Fay, S. Chavin, D. Schroeder, F. Young, and V. Marder, Purification and characterization of a highly purified human factor VIII consisting of a single type of polypeptide chain., Proceedings of the National Academy of Sciences, vol.79, issue.23, pp.7200-7204, 1982.
DOI : 10.1073/pnas.79.23.7200

C. Fulcher and T. Zimmerman, Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody., Proceedings of the National Academy of Sciences, vol.79, issue.5, pp.1648-52, 1982.
DOI : 10.1073/pnas.79.5.1648

H. Gralnick, Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity., Journal of Clinical Investigation, vol.62, issue.2, pp.496-505, 1978.
DOI : 10.1172/JCI109152

R. Robert, R. Anja, Y. M. , C. T. Arnout, F. Mohamed et al., Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation, Blood, vol.93, pp.942-51, 1999.

Y. Bar-dayan, E. Bonnin, and M. Bloch, Neutralization of Disease Associated Autoantibodies by An Immunoglobulin M- and Immunoglobulin A-Enriched Human Intravenous Immunoglobulin Preparation, Scandinavian Journal of Immunology, vol.156, issue.4, pp.408-422, 2000.
DOI : 10.1111/j.1600-065X.1994.tb00858.x

J. Huntington and T. Baglin, Targeting thrombin ??? rational drug design from natural mechanisms, Trends in Pharmacological Sciences, vol.24, issue.11, pp.589-95, 2003.
DOI : 10.1016/j.tips.2003.09.002

C. Ludlam and P. Das, Plasminogen assay by a haemagglutination inhibition technique, Journal of Clinical Pathology, vol.24, issue.2, pp.136-178, 1971.
DOI : 10.1136/jcp.24.2.136

O. Brien, D. Pattinson, J. Tuddenham, and E. , Purification and characterization of factor VIII 372-Cys: a hypo functional cofactor from a patient with moderately severe hemophilia A, Blood, vol.75, pp.1664-72, 1990.

V. Hornsey, B. Griffin, D. Pepper, L. Micklem, and C. Prowse, Immunoaffinity purification of factor VIII complex, Thromb Haemost, vol.57, pp.102-107, 1987.

M. Casey, T. Kiok, L. Linask, K. Mohan, and V. , Production, isolation and purification of plasmids for factor VIII, p.554

D. Pc, Investigations and preparation of fibrinogen coated tanned sheep red cells, J Clin Path, vol.239, pp.149-55, 1970.

D. Goetz, Cross-reactivity among edible nuts: double immunodiffusion, crossed immunoelectrophoresis, and human specific IgE serologic surveys, Annals of Allergy, Asthma & Immunology, vol.95, issue.1, pp.45-52, 2005.
DOI : 10.1016/S1081-1206(10)61187-8

C. Cross and B. , Hemagglutination inhibition assays, Seminars in Avian and Exotic Pet Medicine, vol.11, issue.1, pp.15-23, 2002.
DOI : 10.1053/saep.2002.28236

R. Gupta, The standardization of the reverse indirect haemagglutination test for the assay of the viral antigen of Japanese encephalitis vaccine, Journal of Biological Standardization, vol.15, issue.3, pp.271-280, 1987.
DOI : 10.1016/0092-1157(87)90030-8

K. Dorothy and L. Xing, Single radial immunodiffusion as a method for the assay of the acellular pertussis vaccine components, pertussis toxoid, filamentous haemagglutinin and pertactin, Biological, vol.26, pp.217-241, 1998.

Y. Tai-kim, J. Ault, and R. Wodzinski, Detection of virus-specific antibody-forming cells of mice immunized with Newcastle disease virus, Infect Immun, vol.11, pp.991-996, 1975.

A. Akbarzadeh, D. Norouzian, A. Farhangi, M. Mehrabi, M. Bakhtiari et al., Study of human therapeutic morphine vaccine: safety and immunogenicity, Asain J Biochem, vol.2, pp.58-65, 2007.

W. Ouyang, J. Xue, J. Liu, W. Jia, Z. Li et al., Establishment of an ELISA system for determining soluble LAIR-1 levels in sera of patients with HFRS and kidney transplant, Journal of Immunological Methods, vol.292, issue.1-2, pp.109-126, 2004.
DOI : 10.1016/j.jim.2004.06.005